Atlas Trials

Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism

Clinical trial NCT02558270 · UNKNOWN

Trial details

NCT number
NCT02558270
Sponsor
Medical University of Vienna
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 DiabetesMetabolically Healthy Controls
Start date
2016-06-01
Primary completion
2017-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.